However, based on the pricing of comparable medications (Wegovy at ~$1,350/month and Zepbound at ~$1,060/month), analysts anticipate retatrutide will be priced similarly, potentially between $1,000 and $1,500 per month at list price
Demonstrates persistent cognitive benefits even after treatment cessation, suggesting true structural neurological improvements rather than temporary stimulation, supporting long-term brain health
Every batch is rigorously tested to guarantee its purity and identity
Minimum 6-Month Waiting Period: Safety Considerations At the absolute minimum, Dr
Second, the follow-up durations in several trials were insufficient to assess long-term carcinogenesis